Xeljanz (Tofacitinib) and Xeljanz XR Lawsuits

Our team of attorneys is currently investigating claims that Xeljanz (Tofacitinib) and Xeljanz XR use may be associated with an increased risk of serious heart-related events and cancer.

What We Know About Xeljanz

The FDA already issued two Drug Safety Communications about Xeljanz earlier this year. On February 4, 2021, the FDA issued a Drug Safety Communication alerting that preliminary results from the safety clinical trial show that compared to TNF inhibitor users Xeljanz users have an increased risk of serious heart-related problems and cancer.

On September 1, 2021, the FDA issued another Drug Safety Communication about Xeljanz. The FDA has now concluded that there is an increased risk of “serious heart related events” with Xeljanz and Xeljanz XR, including:

• Heart attack
• Stroke
• Cancer (lung cancer and lymphoma)
• Blood clots
• Death

The FDA further confirmed that Xeljanz poses these risks not only at the higher dose, but also at the lower dose. The FDA is now requiring revisions to Xeljanz’s Boxed Warning to include information about the risks of serious heart-related events, cancer, blood clots, and death.

Recoverable Compensation in a Xeljanz Lawsuit

If you or a loved one were prescribed Xeljanz, then you may be eligible to participate in a lawsuit against Xeljanz’s manufacturers and sellers. If you hire ASK LLP, we will seek the following damages for you:

• Past and future medical expenses
• Past and future pain and suffering
• Past and future wage loss
• Past and future loss of earning capacity
• Past and future loss of enjoyment of life
• Punitive damages, if justified

CALL TODAY! If you have been prescribed Xeljanz, you might be entitled to compensation. Call ASK LLP at (877) RING ASK (877-746-4275) for a free case evaluation.

Why You Should Choose ASK LLP

When you get hurt after using a drug, you may not know what to do. After all, the pharmaceutical industry is a large and powerful one. We are here to help. Our experienced legal team has a strong track record of fighting—and winning—against big pharmaceutical companies. We have already successfully represented more than 15,000 clients who were injured by dangerous, defective drugs. If you hire us, know that we will fight tirelessly to get you the best possible result.